EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling

AM DeHaan, NM Wolters, ET Keller… - The Prostate, 2009 - Wiley Online Library
BACKGROUND Bone metastasis occurs frequently in advanced prostate cancer (PCa)
patients; however, it is not known why this happens. The epidermal growth factor receptor …
被引用次数：50 相关文章
[HTML] nih.gov

[HTML][HTML] EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling

AM DeHaan, NM Wolters, ET Keller, KMW Ignatoski - The Prostate, 2009 - ncbi.nlm.nih.gov
Bone metastasis occurs frequently in advanced prostate cancer (PCa) patients; however, it
is not known why this happens. The epidermal growth factor receptor (EGFR) ligand EGF is …

EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling

AM DeHaan, NM Wolters, ET Keller… - The …, 2009 - pubmed.ncbi.nlm.nih.gov
Background Bone metastasis occurs frequently in advanced prostate cancer (PCa) patients;
however, it is not known why this happens. The epidermal growth factor receptor (EGFR) …

[引用][C] EGFR Ligand Switch in Late Stage Prostate Cancer Contributes to Changes in Cell Signaling and Bone Remodeling

AM DEHAAN, NM WOLTERS, ET KELLER… - The …, 2009 - pascal-francis.inist.fr
EGFR Ligand Switch in Late Stage Prostate Cancer Contributes to Changes in Cell
Signaling and Bone Remodeling CNRS Inist Pascal-Francis CNRS Pascal and Francis …

[引用][C] EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling

Prostate, 2009 - cir.nii.ac.jp
EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and
bone remodeling | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling.

AM DeHaan, NM Wolters, ET Keller, KM Ignatoski - The Prostate, 2009 - europepmc.org
Background Bone metastasis occurs frequently in advanced prostate cancer (PCa) patients;
however, it is not known why this happens. The epidermal growth factor receptor (EGFR) …

EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling

AM DeHaan, NM Wolters, ET Keller, KMW Ignatoski - 2009 - deepblue.lib.umich.edu
BACKGROUND Bone metastasis occurs frequently in advanced prostate cancer (PCa)
patients; however, it is not known why this happens. The epidermal growth factor receptor …

EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling.

AM DeHaan, NM Wolters, ET Keller, KM Ignatoski - The Prostate, 2009 - europepmc.org
Background Bone metastasis occurs frequently in advanced prostate cancer (PCa) patients;
however, it is not known why this happens. The epidermal growth factor receptor (EGFR) …

[引用][C] EGFR Ligand Switch in Late Stage Prostate Cancer Contributes to Changes in Cell Signaling and Bone Remodeling

AM DEHAAN, NM WOLTERS, ET KELLER… - The Prostate, 2009 - Wiley-Liss